Jennifer Woo

Aridis Pharmaceuticals (United States) — United States

Immunology and Microbiology · Life Sciences

26h-index1.8kcitations48works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(9), Respiratory viral infections research(9), Immunotherapy and Immune Responses(8), Immune Cell Function and Interaction(8), Influenza Virus Research Studies(7)

Publications48 total

Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
Nature Communications·2023· 17 citedOpen Access
Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity <i>In Vitro</i> and <i>In Vivo</i> against Methicillin-Resistant <i>Staphylococcus aureus</i>
Molecular Pharmaceutics·2023· 15 cited
WS05.06 Phase 1/2a randomized, double-blind, placebo-controlled study: safety, Pk, and Efficacy outcome measures of inhaled Gallium Citrate (AR-501) in P Aeruginosa infected Cystic Fibrosis patients
Journal of Cystic Fibrosis·2023· 1 citedOpen Access
POS0119 XmAb564, A NOVEL POTENCY-REDUCED IL-2 FC FUSION PROTEIN SELECTIVELY EXPANDS REGULATORY T CELLS: RESULTS FROM A SINGLE ASCENDING DOSE STUDY IN HEALTHY ADULT VOLUNTEERS
2023· 1 citedOpen Access
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
PLoS Pathogens·2022· 37 citedOpen Access
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
2022· 13 citedOpen Access
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Cell Reports Medicine·2021· 72 citedOpen Access
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
2020· 22 citedOpen Access
DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE
Mediterranean Journal of Hematology and Infectious Diseases·2020· 7 citedOpen Access
674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105
Open Forum Infectious Diseases·2019· 8 citedOpen Access
716. In vitro and In vivo Nonclinical Efficacy of AR-501 (Gallium Citrate)
Open Forum Infectious Diseases·2019· 3 citedOpen Access
Novel Antibacterial Compounds for Oral Care
2019
A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation
PLoS ONE·2016· 22 citedOpen Access
Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits
Vaccine·2016· 28 cited
Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV
Clinical and Vaccine Immunology·2016· 49 citedOpen Access
Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo
Vaccine·2015· 23 cited
A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models
PLoS ONE·2015· 53 citedOpen Access
Enzyme-Linked Immunospot Assay for Detection of Human Respiratory Syncytial Virus F Protein-Specific Gamma Interferon-Producing T Cells
Clinical and Vaccine Immunology·2014· 18 citedOpen Access
High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations
Human Pathology·2013· 61 cited
Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells
Journal of Virology·2013· 48 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Vu L. Truong(7), Peter F. Moore(5), Andreas Loos(5), Mark R. Walter(5), Luis Martínez‐Sobrido(5), James J. Kobie(5), Peter F. Moore(5), Michael S. Piepenbrink(4), Jun‐Gyu Park(4), Madhubanti Basu(4), Sanghita Sarkar(4), Chengjin Ye(4), Nathaniel Erdmann(4), Paul A. Goepfert(4), Stacie Lambert(4), Gregory M. Hayes(4), L Gemmell(4), Christopher S. Ambrose(3), Anu Cherukuri(3), Fengrong Zuo(3)